NorthWest Biotherapeutics Inc (NWBO)

[dstock07734]

Are you sure?

Under LP's leadership, a very challenging problem was solved which made franchise possible. NWBO has a case study peer-reviewed paper accepted for publication. UK special program had 200 patients all over the world paying out of their own pockets to receive the treatment. I suspect every expert in immunotherapy would be marveled by the ASCO presentation. Both Dr. Liau and George Zavoico joined NWBO team. NWBO's p3 trial results must be so appealing to NCI that NCI top-notch team did independent analysis on tumor tissues from p3 trial. I can continue listing. Did you expect all of these five or eight years ago?

I think the problem is that we use measure NWBO everyday to see how far it is moving and we should stop and choose a reference from the immunotherapy universe to see how far NWBO is ahead of everyone else. In fact, we are so far ahead that makes some doctors worry about their professions and equity options that they start writing hitting piece one after another.

https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE249282